Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry

8th November 2021

Characteristics and Outcomes of Patients With Severe Aortic Stenosis Discussed by the Multidisciplinary ‘‘Heart Team” According to Treatment Allocation

25th October 2021

‘Valve for Life’: tackling the deficit in transcatheter treatment of heart valve disease in the UK

10th August 2021

Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes

30th June 2021

The cost-effectiveness of TAVR in low surgical risk patients with severe aortic stenosis

2nd June 2021

SCAI/ACVP expert consensus statement on cardiovascular catheterization laboratory economics

1st June 2021

Effective Operational Management in the Cardiac Catheterization Laboratory (Review paper)

Health Status after Transcatheter vs Surgical Aortic Valve Replacement in Low-risk Patients with Aortic Stenosis

Transcatheter Aortic-Valve Replacement with a Balloon Expandable Valve in Low-Risk Patients

Thirty-day readmission after TAVR in the United States: Insights from the Nationwide Readmission Database